Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Pegelow, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pegelow, C. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ACETAMINOPHEN
*CODEINE
*HYDROMORPHONE
*MEPERIDINE
*MORPHINE
Medline Plus Health Information
*Pain
*Sickle Cell Anemia
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Survey of Pain Management Therapy Provided for Children With Sickle Cell Disease

Charles H. Pegelow, M.D.

Department of Pediatrics (R-131), University of Miami School of Medicine, P.O. Box 016960, Miami, FL 33101

A questionnaire was sent to principal investigators of NIH-sponsored clinical research in sickle cell disease. Twenty of 21 respondents indicated they used parenteral narcotic analgesics for pain episodes sufficiently severe to warrant hospitalization. Eleven used meperidine; seven, morphine; and one each, nalbuphine, hydromorphone, and acetaminophen with codeine. They gave the agents at frequent, regular intervals or by continuous infusion. A total of 41 of more than 3,500 patients required chronic transfusion for pain control. Complications included meperidine-associated convulsions reported by nine respondents and addiction by six. This information indicates that vigorous pain-control methods are used at institutions having a special interest in providing medical care for children with sickle cell disease.

Clinical Pediatrics, Vol. 31, No. 4, 211-214 (1992)
DOI: 10.1177/000992289203100404


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
PediatricsHome page
A. J. Daley
Can Exergaming Contribute to Improving Physical Activity Levels and Health Outcomes in Children?
Pediatrics, August 1, 2009; 124(2): 763 - 771.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
S. A. Strassels, E. McNicol, and R. Suleman
Postoperative pain management: A practical review, part 1
Am. J. Health Syst. Pharm., September 15, 2005; 62(18): 1904 - 1916.
[Abstract] [Full Text] [PDF]


Home page
J Health PsycholHome page
M. Griffiths
Can Videogames be Good for Your Health?
J Health Psychol, May 1, 2004; 9(3): 339 - 344.
[PDF]